DexCom, Inc. provided earnings guidance for the year 2022. For the year 2022, the company expects revenue of approximately $2.88 billion to $2.91 billion (18-19% reported growth).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
112.9 USD | +1.92% |
|
-0.97% | -9.27% |
Jul. 10 | DexCom, Inc. : A Must-Have Tool for Diabetes Care | ![]() |
Jun. 26 | Wall Street: up, on the edge, despite rates | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.27% | 44.06B | |
-5.18% | 179B | |
-5.38% | 98.81B | |
-7.42% | 64.7B | |
+17.84% | 44.56B | |
+7.42% | 43.8B | |
+11.84% | 28.28B | |
+20.27% | 25.89B | |
-5.70% | 23.41B | |
-10.49% | 21.99B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- DexCom, Inc. Provides Earnings Guidance for the Year 2022